AI and the Pharmaceutical Industry — Daily Archive
A daily record of how much pharmaceutical companies are putting into AI, where, and for what. Only stories carrying an investment signal — funding, acquisition, equity, partnership, deployment — are included; general AI topics and share-price moves are not. Fifteen functional categories, from drug discovery to finance. Amounts are extracted from source text only; no estimates are produced.
This section covers corporate investment behaviour of pharmaceutical companies, not the efficacy or safety of any medicinal product. Headlines are quoted as published; no claim about product performance is made or implied by this site. Collection and classification are automated and may misclassify or miss items. Disclaimer
Browse by function (past 90 days)
🧬 Drug Discovery73
🧪 Clinical Development3
📑 CTD / Regulatory Submission1
🩺 GCP Operations0
📘 ICH Guidelines & AI0
🛡️ Pharmacovigilance / GVP0
📊 RWE / Evidence Generation1
🎓 Medical Affairs0
💼 Sales1
📣 Marketing0
🚚 Distribution / Supply Chain3
✅ GQP / Quality Assurance1
👥 Human Resources2
💴 Finance & Accounting0
🏛️ Enterprise AI Platform & Governance150
2026-11-03
Tue · 5 items
$1.605B — [Tempus AI Q3 2026 Earnings Call] Tempus AI Turns First Profit as Revenue Jumps 23% to $411.5M; Raises Full-Year Guidance to $1.60B-$1.605B
2026-11-02
Mon · 0 items
No items
2026-11-01
Sun · 0 items
Anthropic’s Mithril acquisition: Claude in drug research
2026-10-31
Sat · 4 items
$247M — AstraZeneca signs up to $247M AI antibody discovery deal with Absci
2026-10-30
Fri · 4 items
€9.4M — Catalan biotech Allox raises €9.4M to advance AI drug-discovery platform
2026-10-29
Thu · 8 items
$100M — Beijing-based BioGeometry gets $100M+ for AI drug R&D
2026-10-28
Wed · 1 items
$3B — New York’s Pathos AI Lands $237M From Bristol Myers Squibb, Hits $3B Valuation
2026-10-27
Tue · 1 items
$3B — Pathos AI Raises $237M at $3B Valuation in Round Led by Bristol Myers Squibb
2026-10-26
Mon · 1 items
【4/14 16:00】Novo Nordisk × OpenAI AI drug discovery partnership; Apple AI chief Giannandrea officially departs Food (dbgW7ZBSpw)
2026-10-25
Sun · 3 items
$3B — Pathos AI Raises $237M Series E at ~$3B Valuation, Led by Bristol Myers Squibb
2026-10-24
Sat · 4 items
$3 billion — AI drug firm Pathos raises $237 million, pushing valuation to $3 billion
2026-10-23
Fri · 0 items
$888 Million — Insilico Medicine Hits First AI-Driven Oncology Milestone in $888 Million Servier Collaboration
2026-10-22
Thu · 7 items
$400B — The $400B Pharma Backend Is Getting an AI Shakeup—and Hourly Billing Is Dead
2026-10-21
Wed · 12 items
¥170 billion — METiS Therapeutics partners with Eli Lilly on AI drug-delivery technology: over $10 million upfront, milestones of up to about ¥170 bil
2026-10-20
Tue · 3 items
$1.1B — Lilly partners with Hong Kong's Metis in $1.1B deal to bolster AI nanoparticle discovery
2026-10-19
Mon · 1 items
AI drug discovery company Elix and Axcelead DDP sign joint research agreement on targeted protein degradation inducers
2026-10-18
Sun · 0 items
$29 million — Managed AI execution startup RapidCanvas raises $29 million led by Vertex Ventures SEA & India
2026-10-17
Sat · 4 items
¥370 trillion — Public-private ¥370 trillion across 17 strategic sectors: Japan's path to winning, read through AI, shipbuilding and drug discovery
2026-10-16
Fri · 8 items
$1.86 Billion — AstraZeneca and Insitro Ink $1.86 Billion AI Drug Discovery Deal
2026-10-15
Thu · 11 items
$600 billion — Nuveen Asset Management released a market commentary stating that artificial intelligence (AI) is reshaping the economic structure of t
2026-10-14
Wed · 4 items
$3m — Vertex Ventures leads $3m seed in AI science startup Drylab
2026-10-13
Tue · 2 items
$311 Million — Enveda Biosciences: $311 Million Series E Fuses Ancient Wisdom With AI-Powered Drug Discovery
2026-10-12
Mon · 0 items
No items
2026-10-11
Sun · 2 items
Beijing Haizhi and Jointown Forge AI Partnership for Pharma Distribution Upgrade
2026-10-10
Sat · 7 items
$40 Billion — Isomorphic Labs Seeks Funding at $40 Billion Valuation as AI Drug Discovery Advances
2026-10-09
Fri · 12 items
$40B — Isomorphic Labs aims for $40B+ valuation in new funding, boosting AI drug discovery race.
2026-10-08
Thu · 7 items
¥46 billion — ByteDance nurtures AI drug discovery in a separate company, raising ¥46 billion in its first funding round
2026-10-07
Wed · 2 items
$75 million — AI biotech raises $75 million to design cancer drugs - Bizwomen
2026-10-06
Tue · 1 items
$42M — RXRX Rises As Tempus AI Deal Locks In $42M
2026-10-05
Mon · 1 items
CRScube Acquires Mednet to Expand AI-Assisted Data Entry in Clinical Trials
2026-10-04
Sun · 0 items
No items
2026-10-03
Sat · 0 items
No items
2026-10-02
Fri · 7 items
$258.7 Billion — AI Is Reshaping Gene Transfer Technologies — $258.7 Billion in VC Signals a Structural Shift in Biotech Investment
2026-10-01
Thu · 2 items
$500M — Ex-Genentech, Meta, AWS AI leaders launch health AI lab with $500M backing
2026-09-30
Wed · 3 items
$2.4 Billion — Roche Pours $2.4 Billion into Autonomous AI Lab as Phase III Success Rate Jumps to 80%
2026-09-28
Mon · 0 items
No items
2026-09-23
Wed · 4 items
$1B — Boehringer Ingelheim bets up to $1B in AI-centered solid tumor collab with Envisagenics
2026-09-22
Tue · 6 items
$400M — Anthropic's $400M Buy Gives New York's Life Sciences' AI Sector a Boost
2026-09-21
Mon · 3 items
US$290m — ByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom
2026-09-20
Sun · 4 items
£20m — £20m robotic AI laboratory targets faster infectious disease drug discovery
2026-09-19
Sat · 9 items
$1.5B — China's AI Drug Discovery Startup Anew Labs Raises $290M at $1.5B Valuation
2026-09-18
Fri · 14 items
¥45 billion — ByteDance spins off AI drug discovery subsidiary, secures $290 million (about 45 billion yen) in first funding round
2026-09-17
Thu · 12 items
$1.5B — ByteDance's Anew Labs raises $290M for AI drug discovery at $1.5B valuation
2026-09-16
Wed · 5 items
$125M — OpenAI Foundation Gives $125M to Public Data for AI-Driven Health Program
2026-09-15
Tue · 3 items
$13.3 Mn — Graph AI Secures $13.3 Mn Series A To Scale AI Drug Safety Platform
2026-09-14
Mon · 0 items
No items
2026-09-13
Sun · 1 items
$4.9 Million — Fundly.ai Raises $4.9 Million to Expand B2B Pharma Platform
2026-09-12
Sat · 3 items
$300M — Genscript to raise $300M in share placing to scale AI drug discovery
2026-09-11
Fri · 2 items
$4 million — Fundly.ai raises $4 million in pharma distribution funding
2026-09-10
Thu · 10 items
$400B — Major Pharma News July–August 2026 | $400B Merger, AI, GLP-1s & India Pharma Updates Ben Stiller (oudY4ulATf)
2026-09-09
Wed · 0 items
No items
2026-09-08
Tue · 7 items
$60M — Superluminal Medicines Raises $60M Series B for AI-Driven GPCR Drug Discovery
2026-09-07
Mon · 3 items
South Korea's Hanmi Pharmaceutical fully adopts AI for quality assurance, training on 4,000 types of documents
2026-09-06
Sun · 0 items
No items
2026-09-05
Sat · 1 items
Does Tempus AI’s (TEM) New ECG-PH Clearance Reveal Its Real Edge In Clinical AI Adoption?
2026-09-04
Fri · 3 items
Chaim---Surges, signs joint research agreement with FRONTEO on AI drug discovery
2026-09-03
Thu · 3 items
€2.5M — Pharosyn Raises €2.5M for Pharma AI Intelligence Platform.
2026-09-02
Wed · 9 items
$2.22 Billion — Study on Artificial Intelligence (AI) Enabled Pharma Supply Chain Market Highlights Industry Expansion to $2.22 Billion
2026-09-01
Tue · 4 items
$2 Billion — Dassault Systèmes to Acquire ArisGlobal for Up to $2 Billion, Integrating Life Sciences AI
2026-08-31
Mon · 1 items
Megazone and Hanmi Science partner to jointly develop pharmaceutical AI - CHOSUNBIZ